ZC3H12A and nonpapillary renal cell carcinoma: ZC3H12A inhibits angiogenesis in ccRCC by degrading transcription factor C/EBPβ and angiogenic factors such as VEGF and IL-8 through its RNase activity [57,58,59,60].